Light Therapy Market is expected to reach US$ 1,434.25 million by 2030

Publisher: The Insight Partners

Skin Disorders Segment to Dominate Light Therapy Market During 2022–2030 

According to our new research study on "Light Therapy Market Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis," the light therapy market size is projected to grow from US$ 930.69 million in 2022 to US$ 1,434.25 million by 2030; the market is anticipated to record a CAGR of 5.6% from 2022 to 2030. Growing prevalence of skin diseases and the rising use of noninvasive therapies is driving the market growth. In 2023, the World Health Organization released estimates that skin diseases impacted over 1.8 million people worldwide. However, the stringent regulatory processes and high cost of devices hinder the growth of the light therapy market.

The rising adoption of blue light therapy for skin disease has emerged as a significant driver propelling the growth and diversification of the light therapy market. Blue light therapy, a noninvasive phototherapy modality, has witnessed increasing utilization for treating various dermatological conditions, including acne, psoriasis, eczema, and actinic keratosis. The efficacy of blue light therapy in targeting specific skin concerns, such as acne vulgaris, has gained widespread attention and acceptance among healthcare professionals and individuals seeking non-pharmacological treatment options. Technological innovations have further amplified the application of blue light therapy, resulting in the development of specialized light delivery systems with optimized blue light wavelengths that selectively target and mitigate the underlying causes of dermatological conditions. The accessibility of home-based blue light therapy devices has also contributed to the market's expansion, empowering individuals to address skin concerns with convenient and user-friendly solutions.

Light Therapy Market, by Region, 2022 (%)

To get free sample copy of the report, along with the TOC, Statistics, and Tables please visit @ https://www.theinsightpartners.com/sample/TIPRE00002883

Source: The Insight Partners Analysis

On the other hand, light therapy offers a range of therapeutic benefits; the risk of side effects associated with certain modalities has emerged as a limiting factor for the overall growth of the light therapy market. Specifically, concerns regarding potential side effects, such as skin irritation, eye strain, and disruption of circadian rhythms, have raised caution among healthcare providers and potential users. These concerns can deter individuals from exploring light therapy options, particularly in cases where there is insufficient information or guidance on safe and appropriate usage. Furthermore, the need for meticulous dosimetry and adherence to treatment protocols, coupled with the potential for adverse reactions in sensitive individuals, presents a barrier to widespread adoption. Mitigating these risks through ongoing research, education, and the development of enhanced safety measures will be crucial for addressing these limitations and fostering greater confidence in the safety and effectiveness of light therapy, thereby encouraging its broader utilization and positively impacting market growth. 

Koninklijke Philips N.V.; Beurer GmbH; BioPhotas; Northern Light Technologies; Lumie; Verilux, Inc; Zepter International; The Daylight Company; Zerigo Health; and Naturebright are among the key players operating in the light therapy market. The companies have been implementing organic (product launches, expansions, and product approvals) and inorganic (product launches, partnerships, and collaborations) strategies that contribute to their growth and lead to market transformation.

In June 2022, BioPhotas, Inc. partnered with Ulta Beauty. With the aid of the Celluma PRO and Celluma ELITE models, this cooperation is anticipated to satisfy customers' skincare needs in 55 distinct areas across the US. The FDA has approved these models to treat several ailments, including wrinkles, joint discomfort, and acne.

The report segments the light therapy market as follows:

Based on geography, the light therapy market is segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. North America is the most significant contributor to the growth of this market owing to the increasing number of people who have psoriasis and SAD/Winter blues symptoms; North America led the world market for light therapy in 2022. Under medical supervision, light treatment entails exposing the skin to UV light from artificial sources. UVB and UVA light, or a mix of the two, are used to alleviate symptoms, lessen inflammation, and limit the proliferation of skin cells. The Canadian Dermatology Association believes that one million Canadians have psoriasis, which is a key factor that drives the demand for light therapy devices. The Asia Pacific light therapy market is expected to record the fastest CAGR from 2022 to 2030, owing to huge investments in telemedicine and increased knowledge of the advantages of light treatment.

Contact Us
Contact Us: The Insight Partners 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com